23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
44.45%
Positive revenue growth while Insurance - Life median is negative. Peter Lynch might see a relative strength advantage in a tough sector.
44.45%
Positive gross profit growth while Insurance - Life median is negative. Peter Lynch would see a notable competitive edge in cost or pricing.
-38.37%
Negative EBIT growth while Insurance - Life median is 25.35%. Seth Klarman would check if external or internal factors caused the decline.
-38.37%
Negative operating income growth while Insurance - Life median is 28.34%. Seth Klarman would check if structural or cyclical issues are at play.
-47.96%
Negative net income growth while Insurance - Life median is 31.53%. Seth Klarman would investigate factors dragging net income down.
-47.95%
Negative EPS growth while Insurance - Life median is 38.75%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-47.95%
Negative diluted EPS growth while Insurance - Life median is 38.32%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.37%
Dividend growth 50-75% of Insurance - Life median of 3.20%. Guy Spier might worry about underperformance in shareholder returns.
-25.81%
Negative OCF growth while Insurance - Life median is -15.96%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-25.81%
Negative FCF growth while Insurance - Life median is -13.92%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
-9.74%
Negative 10Y revenue/share CAGR while Insurance - Life median is 11.61%. Seth Klarman would see if the entire sector or just this company faces long-term decline.
-45.77%
Negative 5Y CAGR while Insurance - Life median is 0.00%. Seth Klarman would see if others are at least growing moderately, indicating a firm-specific problem.
704.29%
3Y revenue/share growth exceeding 1.5x Insurance - Life median of 10.86%. Joel Greenblatt might see a short-term competitive advantage at play.
178.35%
OCF/share CAGR exceeding 1.5x Insurance - Life median of 16.62% over 10 years. Joel Greenblatt would verify if a unique competitive moat underlies these cash flows.
17.00%
OCF/share CAGR of 17.00% while Insurance - Life median is zero. Walter Schloss might see a slight advantage that can compound if momentum builds.
17.60%
3Y OCF/share growth near Insurance - Life median. Charlie Munger would find it typical for industry-level short-term expansions.
15.78%
Net income/share CAGR 75-90% of Insurance - Life median. John Neff would push for cost or revenue enhancements to match peers.
-57.59%
Negative 5Y CAGR while Insurance - Life median is 32.25%. Seth Klarman might see a specific weakness if peers maintain profitable expansions.
18.48%
3Y net income/share CAGR 75-90% of Insurance - Life median. John Neff would seek cost or revenue improvements to match peers.
58.06%
Equity/share CAGR 1.25-1.5x Insurance - Life median. Mohnish Pabrai might credit disciplined reinvestment or conservative payout ratios for outperformance.
1.34%
Below 50% of Insurance - Life median. Jim Chanos suspects weak profitability or questionable capital allocation limiting equity growth.
-3.73%
Negative 3Y equity/share growth while Insurance - Life median is -10.87%. Seth Klarman sees a short-term weakness if peers still expand net worth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3.61%
Asset growth exceeding 1.5x Insurance - Life median of 0.69%. Joel Greenblatt confirms strong expansions matched by adequate returns on those assets.
1730.55%
BV/share growth exceeding 1.5x Insurance - Life median. Joel Greenblatt checks if consistent ROE or undervalued buybacks fuel this advantage.
5.42%
Debt growth far outpacing Insurance - Life median. Jim Chanos suspects over-leveraging or deteriorating financial discipline.
No Data
No Data available this quarter, please select a different quarter.
-6.61%
SG&A decline while Insurance - Life grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.